Children who carry certain mutations associated with cystic fibrosis (CF), but do not have the disease — called CF…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
Researchers have identified a set of genes that could represent therapeutic targets to prevent severe complications from COVID-19 infection in…
The advent of newborn screening (NBS) programs in the U.S. a decade ago is linked to better outcomes today in…
Measures of frailty, based on an established index of physical activity, fatigue, weight loss, and the like for older adults,…
Allergies to beta-lactam antibiotics were the most commonly confirmed antibiotic allergy in children with cystic fibrosis, according to a…
Lumacaftor (VX-809) — one of the medications in the CFTR modulator Orkambi — led to a significant protein reorganization…
Destiny Pharma has received an award from the Cystic Fibrosis Foundation (CFF) to evaluate its investigational compound, XF-73,…
Researchers have developed a way to monitor the onset and progression of lung disease in young children with cystic…
Six months of Kaftrio (elexacaftor-tezacaftor-ivacaftor), which is marketed as Trikafta in the U.S., led to marked reductions in abdominal…
The prevalence of cystic fibrosis (CF), used as an indicator of the number of CF carriers, was correlated with…